Overview
- 165 inspections across 145 sites are on record.
- 213 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-01-31.
At a glance
Inspections
165
Sites
145
Observations
213
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals | 31 Jan 2025 | Human Drugs | On file |
| Nivagen Pharmaceuticals Inc | 23 Oct 2024 | Human Drugs | |
| Generitech Corporation | 3 Sep 2024 | Human Drugs | On file |
| Astellas Pharma Inc. | 18 Apr 2024 | Human Drugs | |
| Takeda Pharmaceutical Company Limited | 12 Apr 2024 | Human Drugs |
Sites inspected
Hahnemann Laboratories, Inc. dba Alpine PharmaceuticalsSan Rafael, United States1 insp.
Nivagen Pharmaceuticals IncPittsburg, United States1 insp.
Generitech CorporationFresno, United States1 insp.
Astellas Pharma Inc.Toyama, Japan1 insp.
Takeda Pharmaceutical Company LimitedYodogawa-Ku, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Carla J Lundi4 shared
Demario L Walls3 shared
Katherine Szestypalow3 shared
Steven E Porter3 shared
Vioela J Caze2 shared
Kristin M Abaonza2 shared
Jennifer M Gogley2 shared
Marcus F Yambot2 shared
David J Gomes2 shared
Nathan E Hellman1 shared
Full investigator report
Get the verbatim findings behind John A Gonzalez's 213 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site